{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:03Z","timestamp":1787242983676,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["#14431901900"],"award-info":[{"award-number":["#14431901900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["#201508310018"],"award-info":[{"award-number":["#201508310018"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011198","name":"CAS | State Key Laboratory of Drug Research","doi-asserted-by":"publisher","award":["#SIMM1903KF-11"],"award-info":[{"award-number":["#SIMM1903KF-11"]}],"id":[{"id":"10.13039\/501100011198","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Climbing Fund of SIPPR"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In the present study, a novel dimer, SM1044, selected from a series of dihydroartemisinin (DHA) derivatives containing nitrogen atoms comprising simple aliphatic amine linkers, showed strong growth inhibition in six types of human endometrial cancer (EC) cells, with half maximal inhibitory concentration (IC\n                    <jats:sub>50<\/jats:sub>\n                    ) and 95% confidence interval (CI)\u2009&lt;\u20093.6 (1.16~11.23) \u03bcM. SM1044 evoked apoptosis and activated caspase-3, \u22128 and \u22129 in a concentration- and time-dependent manner, and these effects were manifested early in RL95-2 compared to KLE cells, possibly correlated with the induction of intracellular ONOO\n                    <jats:sup>\u2212<\/jats:sup>\n                    . Catalase and uric acid attenuated the growth inhibitory effects of SM1044 on EC cells, but sodium pyruvate did not.\n                    <jats:italic>In vivo<\/jats:italic>\n                    , the average xenograft tumour growth inhibition rates ranged from 35.8% to 49.9%, respectively, after 2.5 and 5.0\u2009mg\/kg SM1044 intraperitoneal treatment, and no obvious behavioural and histopathological abnormalities were observed in SM1044-treated mice in this context. SM1044 predominantly accumulated in the uteri of mice after a single injection. SM1044 displayed efficacy as a tumour suppressor with distinct mechanism of action and unique tissue distribution, properties that distinguish it from other artemisinin analogues. Our findings provide a new clue for artemisinin analogue against cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-52108-6","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T16:29:48Z","timestamp":1572452988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel dihydroartemisinin dimer containing nitrogen atoms inhibits growth of endometrial cancer cells and may correlate with increasing intracellular peroxynitrite"],"prefix":"10.1038","volume":"9","author":[{"given":"Yan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9327","authenticated-orcid":false,"given":"Jung-Chien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5753-6824","authenticated-orcid":false,"given":"Shuwu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-3800","authenticated-orcid":false,"given":"Peter C. K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"52108_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"38","author":"P Morice","year":"2016","unstructured":"Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N. & Darai, E. Endometrial cancer. Lancet. 38, 1094\u20131108 (2016).","journal-title":"Lancet."},{"key":"52108_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 136, E359\u201386, https:\/\/doi.org\/10.1002\/ijc.29210 (2015).","journal-title":"Int. J. Cancer."},{"key":"52108_CR3","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2217\/fon.14.192","volume":"10","author":"MA Sheikh","year":"2014","unstructured":"Sheikh, M. A. et al. USA endometrial cancer projections to 2030: should we be concerned? Future Oncol. 10, 2561\u20138 (2014).","journal-title":"Future Oncol."},{"key":"52108_CR4","first-page":"881","volume":"48","author":"L Wei","year":"2013","unstructured":"Wei, L. Emphasis on screening of endometrial cancer. Zhonghua Fuchan Ke Zazhi. 48, 881\u2013883 (2013).","journal-title":"Zhonghua Fuchan Ke Zazhi."},{"key":"52108_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11912-011-0192-x","volume":"13","author":"T Hogberg","year":"2011","unstructured":"Hogberg, T. What is the role of chemotherapy in endometrial cancer? Curr Oncol Rep. 13, 433\u201341 (2011).","journal-title":"Curr Oncol Rep."},{"key":"52108_CR6","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","volume":"17","author":"JT Thigpen","year":"1999","unstructured":"Thigpen, J. T. et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol. 17, 1736\u201344 (1999).","journal-title":"J Clin Oncol."},{"key":"52108_CR7","first-page":"41","volume":"9","author":"EM Stringer","year":"2013","unstructured":"Stringer, E. M. & Fleming, G. F. Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma. Oncol Hematol Rev. 9, 41\u201344 (2013).","journal-title":"Oncol Hematol Rev."},{"key":"52108_CR8","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edition, April 2015. Available at, https:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/."},{"key":"52108_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","volume":"31","author":"HC Lai","year":"2013","unstructured":"Lai, H. C., Singh, N. P. & Sasaki, T. Development of artemisinin compounds for cancer treatment. Investig New Drugs. 31, 230\u2013246 (2013).","journal-title":"Investig New Drugs."},{"key":"52108_CR10","first-page":"767","volume":"18","author":"T Efferth","year":"2001","unstructured":"Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H. & Chitambar, C. R. The anti-malarial artesunate is also active against cancer. Int J Oncol. 18, 767\u201373 (2001).","journal-title":"Int J Oncol."},{"key":"52108_CR11","first-page":"1819","volume":"33","author":"GR Rutteman","year":"2013","unstructured":"Rutteman, G. R. et al. Safety and efficacy field study of artesunate for dogs with non-resectable tumours. Anticancer Res. 33, 1819\u201327 (2013).","journal-title":"Anticancer Res."},{"key":"52108_CR12","first-page":"249","volume":"12","author":"SA Olumide","year":"2011","unstructured":"Olumide, S. A. & Raji, Y. Long-term administration of artesunate induces reproductive toxicity in male rats. J Reprod Infertil. 12, 249\u201360 (2011).","journal-title":"J Reprod Infertil."},{"key":"52108_CR13","first-page":"4417","volume":"31","author":"FH Jansen","year":"2011","unstructured":"Jansen, F. H. et al. First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res. 31, 4417\u20134422 (2011).","journal-title":"Anticancer Res."},{"key":"52108_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","volume":"2","author":"S S. Krishna","year":"2015","unstructured":"S. Krishna, S. et al. A randomised, double blind, placebo-Controlled pilot study of oral artesunate therapy for colorectal cancer. EBioMedicine 2, 82\u201390 (2015).","journal-title":"EBioMedicine"},{"key":"52108_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-017-4261-1","volume":"164","author":"C von Hagens","year":"2017","unstructured":"von Hagens, C. et al. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2). Breast Cancer Res Treat. 164, 59\u2013369 (2017).","journal-title":"Breast Cancer Res Treat."},{"key":"52108_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth, T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol. 46, 65\u201383 (2017).","journal-title":"Semin Cancer Biol."},{"key":"52108_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/aps.2012.104","volume":"33","author":"Y Li","year":"2012","unstructured":"Li, Y. Qinghaosu (artemisinin): Chemistry and pharmacology. Acta Pharmacol. Sin. 33, 1141\u201346 (2012).","journal-title":"Acta Pharmacol. Sin."},{"key":"52108_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1021\/jm990552w","volume":"43","author":"Y Li","year":"2000","unstructured":"Li, Y. et al. Synthesis and antimalarial activity of artemisinin derivatives containing an amino group. J Med Chem. 43, 1635\u201340 (2000).","journal-title":"J Med Chem."},{"key":"52108_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/jm020119d","volume":"46","author":"M Jung","year":"2003","unstructured":"Jung, M. et al. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer. J Med Chem. 46, 987\u201394 (2003).","journal-title":"J Med Chem."},{"key":"52108_CR20","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1021\/jm030974c","volume":"47","author":"JP Jeyadevan","year":"2004","unstructured":"Jeyadevan, J. P. et al. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl) deoxoartemisinin. J Med Chem. 47, 1290\u20138 (2004).","journal-title":"J Med Chem."},{"key":"52108_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1021\/np9605495","volume":"60","author":"AC Beekman","year":"1997","unstructured":"Beekman, A. C. et al. Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. J Nat Prod. 60, 325\u2013330 (1997).","journal-title":"J Nat Prod."},{"key":"52108_CR22","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.bmc.2008.12.017","volume":"17","author":"J Chadwick","year":"2009","unstructured":"Chadwick, J., Mercer, A. E., Park, B. K., Cosstick, R. & O\u2019Neill, P. M. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P.falciparum malaria parasites and HL-60 cancer cells. Bioorg Med Chem. 17, 1325\u20131338 (2009).","journal-title":"Bioorg Med Chem."},{"key":"52108_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bmcl.2005.11.074","volume":"16","author":"M Jung","year":"2006","unstructured":"Jung, M., Tak, J., Chung, W. Y. & Park, K. K. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane. Bioorg Med Chem Lett. 16, 1227\u201330 (2006).","journal-title":"Bioorg Med Chem Lett."},{"key":"52108_CR24","first-page":"4111","volume":"31","author":"NP Singh","year":"2011","unstructured":"Singh, N. P. et al. Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo. Anticancer Res. 31, 4111\u201314 (2011).","journal-title":"Anticancer Res."},{"key":"52108_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/10408441003610571","volume":"40","author":"T Efferth","year":"2010","unstructured":"Efferth, T. & Kaina, B. Toxicity of the antimalarial artemisinin and its derivatives. Crit Rev Toxicol. 40, 405\u201321 (2010).","journal-title":"Crit Rev Toxicol."},{"key":"52108_CR26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1128\/AAC.38.8.1813","volume":"38","author":"DL Wesche","year":"1994","unstructured":"Wesche, D. L., DeCoster, M. A., Tortella, F. C. & Brewer, T. G. Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother. 38, 1813\u20139 (1994).","journal-title":"Antimicrob Agents Chemother."},{"key":"52108_CR27","unstructured":"Murayama, K., Singh, N. N., Helmrich, A. & Barnes, D. W. Neural cell lines. In Protocols for Neural Cell Culture, (3rd ed. Fedoroff, S. & Richardson, A.) 219\u201328 (Humana Press: 2008)."},{"key":"52108_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0960-0760(97)00202-1","volume":"64","author":"E Castro-Rivera","year":"1998","unstructured":"Castro-Rivera, E. & Safe, S. Estrogen-and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. J Steroid Biochem Mol Biol. 64, 287\u201395 (1998).","journal-title":"J Steroid Biochem Mol Biol."},{"key":"52108_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF02618053","volume":"19","author":"DL Way","year":"1983","unstructured":"Way, D. L., Grosso, D. S., Davis, J. R., Surwit, E. A. & Christian, C. D. Characterization of new human endome-trial carcinoma (RL95-2) established in tissue culture. In Vitro. 19, 147\u201358 (1983).","journal-title":"In Vitro."},{"key":"52108_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3892\/or.2012.1807","volume":"28","author":"Y Gao","year":"2012","unstructured":"Gao, Y., Liu, T., Cheng, W. & Wang, H. Isolation and characterization of proliferative, migratory and multidrug resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines. Oncol. Rep. 28, 527\u201332 (2012).","journal-title":"Oncol. Rep."},{"key":"52108_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-4731(89)90320-8","volume":"33","author":"S Kassan","year":"1989","unstructured":"Kassan, S., Mechanick, J. I. & Gurpide, E. Altered estrogen receptor system in estrogen-unresponsive human endometrial adenocarcinoma cells. J Steroid Biochem. 33, 327\u201333 (1989).","journal-title":"J Steroid Biochem."},{"key":"52108_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0090-8258(84)90080-5","volume":"17","author":"GS Richardson","year":"1984","unstructured":"Richardson, G. S. et al. KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol. Oncol. 17, 213\u201330 (1984).","journal-title":"Gynecol. Oncol."},{"key":"52108_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","volume":"108","author":"A Doll","year":"2008","unstructured":"Doll, A. et al. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem. Mol. Biol. 108, 221\u20139 (2008).","journal-title":"J Steroid Biochem. Mol. Biol."},{"issue":"1","key":"52108_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1749-0774.2003.tb00128.x","volume":"16","author":"T. Fujisawa","year":"2003","unstructured":"Fujisawa, T. et al. VEGF expression and its regulation by p53 gene transfection in endometrial carci- noma cells. Hum Cell. 16, 47-54 (2003).","journal-title":"Human Cell"},{"key":"52108_CR35","first-page":"6506","volume":"51","author":"Y Yaginuma","year":"1991","unstructured":"Yaginuma, Y. & Westphal, H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res. 51, 6506\u20139 (1991).","journal-title":"Cancer Res."},{"key":"52108_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","volume":"127","author":"C Korch","year":"2012","unstructured":"Korch, C. et al. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancyand contamination. Gynecol Oncol. 127, 241\u20138 (2012).","journal-title":"Gynecol Oncol."},{"key":"52108_CR37","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1073\/pnas.0803379105","volume":"105","author":"A Dutt","year":"2008","unstructured":"Dutt, A. et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc Natl Acad Sci USA 105, 8713\u20137 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52108_CR38","first-page":"607","volume":"19","author":"JJ Liu","year":"2011","unstructured":"Liu, J. J. et al. A new artemisinin derivative SM1044 induces apoptosis of Kasumi-1 cells and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 19, 607\u201311 (2011).","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"52108_CR39","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1017\/S1462399409001239","volume":"11","author":"GL Firestone","year":"2009","unstructured":"Firestone, G. L. & Sundar, S. N. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med. 11, e32, https:\/\/doi.org\/10.1017\/S1462399409001239 (2009).","journal-title":"Expert Rev Mol Med."},{"key":"52108_CR40","doi-asserted-by":"publisher","first-page":"247597","DOI":"10.1155\/2012\/247597","volume":"2012","author":"MP Crespo-Ortiz","year":"2012","unstructured":"Crespo-Ortiz, M. P. & Wei, M. Q. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2012, 247597, https:\/\/doi.org\/10.1155\/2012\/247597 (2012).","journal-title":"J Biomed Biotechnol."},{"key":"52108_CR41","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jinorgbio.2009.07.011","volume":"103","author":"L Gebicka","year":"2009","unstructured":"Gebicka, L. & Didik, J. Catalytic scavenging of peroxynitrite by catalase. J Inorg Biochem. 103, 1375\u20139 (2009).","journal-title":"J Inorg Biochem."},{"key":"52108_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S. & Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 87, 315\u2013424 (2007).","journal-title":"Physiol Rev."},{"key":"52108_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0304-4165(94)00197-6","volume":"1244","author":"S Pou","year":"1995","unstructured":"Pou, S., Nguyen, S. Y., Gladwell, T. & Rosen, G. M. Does peroxynitrite generate hydroxyl radical? Biochim Biophys Acta. 1244, 62\u20138 (1995).","journal-title":"Biochim Biophys Acta."},{"key":"52108_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0378-4274(02)00508-8","volume":"140\u2013141","author":"L Vir\u00e1g","year":"2003","unstructured":"Vir\u00e1g, L., Szab\u00f3, E., Gergely, P. & Szab\u00f3, C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett. 140\u2013141, 113\u201324 (2003).","journal-title":"Toxicol Lett."},{"key":"52108_CR45","doi-asserted-by":"publisher","first-page":"pii: E1337","DOI":"10.3390\/ijms18071337","volume":"18","author":"A Ma","year":"2017","unstructured":"Ma, A., Xie, S., Zhou, J. & Zhu, Y. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a. Int. J. Mol. Sci. 18, pii: E1337, https:\/\/doi.org\/10.3390\/ijms18071337 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"52108_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0035-9203(02)90256-7","volume":"96","author":"A Nontprasert","year":"2002","unstructured":"Nontprasert, A. et al. Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Trans R Soc Trop Med Hyg. 96, 9\u2013101 (2002).","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"52108_CR47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","volume":"81","author":"JF Deeken","year":"2018","unstructured":"Deeken, J. F. et al. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol. 81, 587\u2013596 (2018).","journal-title":"Cancer Chemother Pharmacol."},{"key":"52108_CR48","unstructured":"Li, Y. et al. Qinghaosu dimer containing nitrogen atom(s), its preparation and use. Chinese Patent 201110034154.9, Jan 31 (2011)."},{"key":"52108_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jff.2015.06.057","volume":"18","author":"Y Zhu","year":"2015","unstructured":"Zhu, Y. et al. Ginsenoside Rh2 suppresses growth of uterine leiomyoma in vitro and in vivo and may regulate ER\u03b1\/c-Src\/p38 MAPK activity. J. Funct. Foods. 18, 73\u201382 (2015).","journal-title":"J. Funct. Foods."},{"key":"52108_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nprot.2007.25","volume":"2","author":"CL Morton","year":"2007","unstructured":"Morton, C. L. & Houghton, P. J. Establishment of human tumor xenografts in immune deficient mice. Nat. Protoc. 2, 247\u201350 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52108-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:09:13Z","timestamp":1671271753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52108-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52108-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15528"}}